摘要: Phenylpropanolamine (PPA) is a relatively common non-prescription sympathomimeticamine. As such, it is frequently detected during forensic analysis. The presence of phenylpropanolamine can be confirmed by using Gas Chromatograph-F... 展开 Phenylpropanolamine (PPA) is a relatively common non-prescription sympathomimeticamine. As such, it is frequently detected during forensic analysis. The presence of phenylpropanolamine can be confirmed by using Gas Chromatograph-Fourier Transform Infrared (GC-FTIR) spectrophotometry. One constraint of the GC-FTIR is the quantity of material required to obtain a suitable IR spectrum. If a drug is a relatively weak infrared absorber, several micrograms may be required in order to obtain a clear, reliable spectrum. While this amount of material may be readily available for some types of analysis, it can easily exceed the quantity of material available in the forensic toxicology setting. One method that can be used to increase a drug's infrared absorption is to derivatize the drug with a polyfluorinated acid anhydride. Since carbonyl and carbon-fluorine bonds are strong infrared absorbers, molecules that possess such bonds have a heightened sensitivity to GC-FTIR analysis. Polyfluorinated acid anhydrides are capable of adding both carbonyl and carbon-fluorine bonds to drugs that possess either a hydroxyl, primary or secondary amine, or primary or secondary amide functional groups. Several derivatizing reagents were used and the extent to which they enhanced the identification of phenylpropanolamine were compared. Of the reagents studied, heptafluorobutyric acid anhydride (HFAA) produced the greatest increase in the phenylpropanolamine's sensitivity to GC-FTIR identification. Prior to derivatization, 1.8 micrograms of phenylpropanolamine was required for identification on the GC-FTIR, while only 0.032 micrograms of phenylpropanolamine was required after derivatization with HFAA. GC-FTIR, Drugs, Phenylpropanolamine. 收起